I recently had customer call me to place an order for prepackaged pharmaceuticals.  This dispensing physician was getting ready to leave on vacation for a week and asked to have the order arrive at his office on a specific day.  I gladly took his order, recorded the details and sent it to the team for processing.  In his case, he likes to personally receive medications and make sure everything matches up.  No problem.  I didn’t think anything about; in fact, we frequently accommodate these requests from our dispensing clinics.

A week later, I was interacting with the faceless, impersonal machine of one of my vendors and my customer came to mind.  Schedule an order with a giant company for delivery on a specific date?  If they had it in inventory, I might get it on a specific date with overnight shipping.  Call my rep to ask a question?  Not unless I could wait 3-4 hours for him/her to get back with me.  It is easy to forget the power of the little things.  I still have clinic staff that call me on my cell phone or email me directly for all of their medication orders.  I don’t mind; in fact, I’m quite thankful that they did call or email.  Pharmaceutical wholesalers can be notoriously unresponsive or slow.  I want my medical clinic customers to know that we really value them – even with the small orders.  Physicians, nurses, dentists and staff from our clinic customers are very busy serving their patients.  We need to be ready when they are.

Well, I have to go…a customer is calling.

Schedule a free claims analysis now.

Let’s Talk now

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading